Weight Loss Injections
Advanced medical weight loss treatments with proven results for sustainable weight management
Available Weight Loss Medications
At Nords Weight Loss Clinic, we offer FDA-approved weight loss medications tailored to your individual health needs. Our specialists provide comprehensive medical oversight to ensure safe and effective treatment.
Ozempic (Semaglutide)
Ozempic is a prescription medication for treating type 2 diabetes and reducing the risk of some heart diseases. It is provided as an injection under the skin. The medication works by mimicking the natural glucagon-like peptide-1 (GLP-1) hormone in your body. GLP-1 regulates appetite and food intake and helps control blood sugar levels. Ozempic helps you adhere to a lower-calorie diet by slowing digestion and increasing feelings of fullness. At Nords, our specialists assess your health condition, provide personalized dosing schedules, and monitor your progress closely. We combine this clinical support with expert nutritional guidance to ensure you achieve and maintain your weight goal safely and effectively.
Zepbound (Tirzepatide)
Zepbound is a medication approved to treat overweight and obesity. This is a prescription medication and you are suggested to pair it with healthy lifestyle practices. It works by mimicking two natural hormones: GLP-1 and glucose-dependent insulinotropic polypeptide (GIP). This 'dual-action' approach enables highly effective weight loss and enhances overall metabolic health, offering a powerful option for those who have struggled with traditional methods. Our team provides expert oversight to ensure your treatment is safe, effective, and tailored to your unique health journey.
Mounjaro (Tirzepatide)
Mounjaro is a medication approved to treat type 2 diabetes and obesity. Based on your individual health condition, the healthcare professional suggests the dosing and other lifestyle modifications for best results. The medication works by mimicking two natural hormones: GLP-1 and glucose-dependent insulinotropic polypeptide (GIP). This "dual-action" approach enables highly effective blood sugar control and significantly enhances overall metabolic health. We provide expert oversight to ensure this treatment is used safely and effectively as part of your health journey.
Lose up to 15% of body weight with Weight Loss Injections
Weekly Injectable Medication
Weight loss injections are once-a-week injectable medication administered subcutaneously (under the skin), typically in the thigh, abdomen, or upper arm.
Professional Guidance & Support
At Nords, our medical team will guide you through your first injection and provide support for self-administration at home if you qualify.
Supervised Safety Protocol
All injections are supervised by trained professionals to ensure safety and correct dosing.
Frequently Asked Questions
Expert answers to your weight loss injection questions
In the current clinical landscape, the strongest injectable medications for weight loss are those in the GLP-1 (glucagon-like peptide-1) / GIP (glucose-dependent insulinotropic polypeptide) receptor agonist class.
For example, Semaglutide (brand names like Wegovy when used for weight loss) and Tirzepatide (brand name Zepbound for weight‐loss indication) currently offer the greatest efficacy. Semaglutide is well supported by trials for weight management; tirzepatide appears to deliver even greater weight loss in comparative studies.
In short: if "best" means the greatest average weight‐loss potential (with appropriate monitoring and lifestyle support), then tirzepatide (dual‐agonist) currently leads, followed closely by semaglutide (single GLP-1 agonist). But "best" also depends on patient suitability, cost, access, side-effect profile, and local regulatory approval.
First, important context: Ozempic (semaglutide) is approved for type 2 diabetes rather than for primary weight‐loss indication (though it does cause weight loss).
In studies of semaglutide used for weight loss (sometimes under other brand names/doses), the typical weight‐loss figures help set expectations: one cohort lost a mean of ~6.7 kg at 3 months (≈5.9% of body weight) and ~12.3 kg at 6 months (~10.9%) in patients with obesity/overweight.
Breaking that down to "per month" gives about 2–4 kg in the early months for many (depending on baseline body‐weight, dose, diet, exercise). Some sources say about 1‐3 pounds (~0.5-1.5 kg) a week (thus 2-6 kg a month) in favourable circumstances.
Yes, but with important caveats. They can be safe and effective when used under medical supervision, but they are not without risk, require appropriate patient selection, monitoring, and integration with lifestyle changes.
There is no single answer; duration depends on the drug, the indication (diabetes vs obesity), response, tolerance, cost, and long-term management plan.
For semaglutide (and by extension off-label use like Ozempic for weight loss):
- Many providers consider usage for at least 12 to 24 months for chronic weight management.
- Some long‐term studies of semaglutide have data out to 2 years (68 weeks and beyond) showing sustained use is feasible.
- Some clinicians treat "indefinitely" (i.e., long-term) as long as the drug remains safe for the patient and effective.
This is a critically important topic to convey clearly: stopping weight‐loss injections often leads to relapse or regain of body weight, especially if lifestyle changes have not become deeply established and support is not maintained.
Here are key contraindications, cautions and patient types to discuss:
Contraindications (i.e., should generally not take unless under very special supervision):
- Personal or family history of medullary thyroid carcinoma (MTC).
- Multiple endocrine neoplasia syndrome type 2 (MEN2) – a known endocrine tumour predisposition.
- Known hypersensitivity to semaglutide or any of its components.
Precautions / when to discuss carefully with provider:
- Those with pancreatitis history or severe pancreatic disease.
- Severe renal impairment / severe gastrointestinal disease (due to risk of delayed gastric emptying or other GI side‐effects) – the prescribing information advises caution.
- Pregnancy or planned pregnancy / breastfeeding: It is not known if Ozempic is safe in pregnancy or breastfeeding; guidelines typically advise stopping ~2 months before attempting pregnancy.
- Children/adolescents (unless specific approved indication).
In your counselling for your bariatric-care context, advise: "We will undertake a full assessment (thyroid history, endocrine history, renal/ pancreatic function, pregnancy plans) before considering Ozempic."